Case Report: External photographs of a 58-year old caucasian male with Crohn\'s disease treated with ten years of minocycline (see [Fig. 1](#fig1){ref-type="fig"}). He was originally treated with 200 mg per day of minocycline for 9 years and then decreased to 100 mg per day for one year prior to presentation (cumulative dose: 693 g). Anterior segment exam revealed bilateral slate-grey pigmentation of the sclera (1A-D) and discrete black conjunctival deposits in the fornices of both lower lids (1E, 1F). There was similar discoloration of his facial skin, pinnae, and nail beds. Gonioscopy did not reveal pigmentary changes or masses. Visual acuity was 20/20 and intraocular pressures were 14 in both eyes. Fundus exam and fundus autofluorescence were normal, and anterior segment OCT (AS-OCT) showed no scleral thinning (1G, 1H). The patient denied using mascara or glaucoma drops. Additionally, he denied excreting dark urine.Fig. 1A-D scleral pigmentation of both eyes. 1E-F conjunctival deposits in inferior fornix of both eyes. 1G-H anterior segment OCT through areas of pigmentation without evidence of scleral thinning.Fig. 1

The patient is currently receiving Q-switched ruby laser treatment for his facial hyperpigmentation and is undergoing cosmetic scleral contact lens fitting to mask the ocular pigmentation.

Discussion & Conclusion: Given the patient\'s history and negative review of systems, we arrived at the diagnosis of minocycline-associated dermal and ocular hyperpigmentation. Ocular pigmentation is a rare side effect of tetracyclines.[@bib1] Among the tetracyclines, pigmentation of the sclera and skin is most commonly associated with minocycline use due to its lipophilic properties.[@bib2] Examination of patients with similar presentations necessitates consideration of melanotic disorders such as ocular or oculodermal melanocytosis which is occasionally bilateral, inborn errors of metabolism such as alkaptonuria, inflammatory causes, and medication-related etiologies (e.g. topical epinephrine or silver exposure). The presence of pigmentation at the level of the sclera and conjunctiva simultaneously, however, may differentiate this diagnosis from ocular melanocytosis which notably does not present with conjunctival pigmented deposits. Additionally, these conjunctival deposits are known to fluoresce due to their naphthacene carboxamide ring, which may further aid in making the diagnosis.[@bib3]^,^[@bib4] In cases with consistent histories or autofluorescence of conjunctival deposits, careful monitoring may be preferable to conjunctival biopsy.[@bib4]

To the best of the authors\' knowledge, this is the first multimodal imaging of minocycline-associated ocular hyperpigmentation. The conjunctival deposits are a rare but important clue that help differentiate this presentation from oculodermal melanocytosis and other etiologies of scleral pigmentation. Our case reinforces the importance of a thorough differential with particular attention to onset, laterality, presence of intraocular pigmentation and exposure history.

Patient Consent: Written consent to publish this case has not been obtained. This report does not contain any personal identifying information.
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